Family Medicine · Texarkana, TX
NPI
1114920972
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3333 Potomac Ave
Texarkana, TX, 75503
Phone (903) 792-3787
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
3,579 services
Medicare patients, 2024
656
Average age 75
Drug cost, 2024
$495K
3,865 prescriptions
Company payments, 2024
$197
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott W Wyrick was code 17003 (destruction skin lesion), 1,732 times for 275 patients. In total Scott W Wyrick billed 3,579 services in 41 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,732 | 275 | $4.23 | $7,331 |
| 99212 Office E&M - Established | Office | 494 | 342 | $34.39 | $17K |
| 17000 Destruction Skin Lesion | Office | 446 | 318 | $36.70 | $16K |
| 17110 Destruction Skin Lesion | Office | 244 | 221 | $71.58 | $17K |
| 99213 Office E&M - Established | Office | 192 | 156 | $53.95 | $10K |
| 99203 Office E&M - New | Office | 169 | 169 | $65.60 | $11K |
| 17004 Destruction Skin Lesion | Office | 58 | 41 | $106.99 | $6,205 |
| 10040 Removal or Shaving of Skin Growth | Office | 23 | 23 | $77.04 | $1,772 |
By year: 2022 $125K for 4,373 services; 2023 $113K for 4,014 services; 2024 $110K for 3,579 services.
Medicare prescription drug claims, 2024
In 2024, the drug Scott W Wyrick prescribed most often to Medicare patients was Hydrocortisone, with 590 prescriptions and refills. In total Scott W Wyrick wrote 3,865 Medicare prescriptions that cost $495K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocortisone Generic | 590 | 621 | 234 | $3,090 |
| Hydroxyzine Hcl Generic | 436 | 477 | 181 | $12K |
| Minocycline Hcl Generic | 383 | 464 | 143 | $4,946 |
| Betamethasone Valerate Generic | 375 | 389 | 146 | $11K |
| Nystatin Generic | 253 | 268 | 112 | $3,149 |
| Triamcinolone Acetonide Generic | 248 | 284 | 126 | $3,221 |
| Dexamethasone Generic | 189 | 189 | 165 | $417 |
| Fluticasone Propionate Generic | 140 | 155 | 42 | $4,712 |
| Clobetasol Propionate Generic | 140 | 157 | 41 | $7,682 |
| Mometasone Furoate Generic | 139 | 145 | 51 | $2,763 |
| Clindamycin Phosphate Generic | 131 | 142 | 44 | $7,173 |
| Ciclopirox Ciclopirox Olamine | 121 | 123 | 44 | $1,772 |
| Doxepin Hcl Generic | 79 | 83 | 24 | $707 |
| Metronidazole Generic | 67 | 67 | 27 | $3,815 |
| Doxycycline Hyclate Generic | 57 | 69 | 12 | $1,478 |
Brand drugs: 448 claims; generic drugs: 3,417 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Scott W Wyrick $197 ($197 in general payments such as food, travel and fees) from 3 companies. The largest payer was Dermavant Sciences, Inc. with $137.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.